Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia

Authors

  • Naohiro Watanabe Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
  • Yoshio Nakahara Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
  • Hiroyuki Taniguchi Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
  • Tomoki Kimura Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
  • Yasuhiro Kondoh Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
  • Kensuke Kataoka Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan
  • Koji Sakamoto Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan

DOI:

https://doi.org/10.3109/0284186X.2013.802838

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2014-01-01

How to Cite

Watanabe, N., Nakahara, Y., Taniguchi, H., Kimura, T., Kondoh, Y., Kataoka, K., & Sakamoto, K. (2014). Crizotinib-induced acute interstitial lung disease in a patient with EML4-ALK positive non-small cell lung cancer and chronic interstitial pneumonia. Acta Oncologica, 53(1), 158–160. https://doi.org/10.3109/0284186X.2013.802838

Issue

Vol. 53 No. 1 (2014): Acta Oncologica

Section

Articles